Provided by Tiger Fintech (Singapore) Pte. Ltd.

Assembly Biosciences

18.45
+0.12000.65%
Post-market: 18.450.00000.00%16:10 EDT
Volume:21.31K
Turnover:390.18K
Market Cap:140.91M
PE:-3.01
High:18.50
Open:18.18
Low:17.87
Close:18.33
Loading ...

Guggenheim Sticks to Their Buy Rating for Assembly Biosciences (ASMB)

TIPRANKS
·
02 Jul

BRIEF-Assembly Biosciences Doses First Participant In Phase 1B Portion Of Phase 1A/B Clinical Trial Of Investigational Long-Acting Herpes Simplex Virus Helicase-Primase Inhibitor Abi-1179

Reuters
·
30 Jun

Assembly Biosciences Doses First Participant in Phase 1B Portion of Phase 1a/B Clinical Trial of Investigational Long-Acting Herpes Simplex Virus Helicase-Primase Inhibitor Abi-1179

THOMSON REUTERS
·
30 Jun

Assembly Biosciences Inc - Interim Data for Abi-5366 and Abi-1179 Expected in Fall 2025

THOMSON REUTERS
·
30 Jun

Assembly Biosciences Reports Positive Phase 1b Trial Results

TIPRANKS
·
26 Jun

Assembly Biosciences Says ABI-4334 Phase 1b Trial Showed 'Strong' Antiviral Activity in Chronic Hepatitis B

MT Newswires Live
·
25 Jun

BRIEF-Assembly Biosciences Reports Positive Topline Results from Phase 1b Clinical Trial of Assembly Modulator in Chronic Hepatitis B

Reuters
·
25 Jun

Assembly Biosciences Inc - Abi-4334 Well-Tolerated With Favorable Safety Profile

THOMSON REUTERS
·
25 Jun

Assembly Biosciences Reports Positive Topline Results From Phase 1B Clinical Trial of Next-Generation Investigational Capsid Assembly Modulator Abi-4334 in Chronic Hepatitis B

THOMSON REUTERS
·
25 Jun

BRIEF-Assembly Biosciences Inc - Jeanette M. Bjorkquist Appointed Principal Financial Officer On June 5- SEC Filing

Reuters
·
10 Jun

Assembly Biosciences Inc - Jeanette M. Bjorkquist Appointed Principal Financial Officer on June 5- SEC Filing

THOMSON REUTERS
·
10 Jun

Assembly Biosciences Inc. Conducted Annual Stockholders Meeting

Reuters
·
10 Jun

Mizuho Securities Sticks to Its Buy Rating for Assembly Biosciences (ASMB)

TIPRANKS
·
22 May

Mizuho Cuts Price Target on Assembly Biosciences to $29 From $36, Keeps Outperform Rating

MT Newswires Live
·
21 May

Assembly Biosciences Inc : Mizuho Cuts Target Price to $29 From $36

THOMSON REUTERS
·
21 May

Assembly Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Assembly Biosciences Q1 EPS $(1.17) Beats $(1.60) Estimate, Sales $9.42M Beat $7.63M Estimate

Benzinga
·
09 May

Assembly Biosciences announces preclinical data, to present at EASL Congress

TIPRANKS
·
07 May

Assembly Biosciences Inc expected to post a loss of $1.60 a share - Earnings Preview

Reuters
·
02 May

Assembly Biosciences (NASDAQ:ASMB) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.
·
02 May